All In Biotech

Drug Trial Radar · NCT00225615

A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels

A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels

Last checked: Nov 20, 2026Latest source record: Aug 20, 2009 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

100

Actual

Start

Nov 2005

Primary completion

Not stated

Study completion Jun 2006

Sponsor

Lead sponsor
BioMarin PharmaceuticalBioMarin (BMRN)
Sponsor type
Industry
First posted
Sep 26, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 8 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this trial is to evaluate the safety and tolerability of long-term Phenoptin treatment in subjects with PKU.

Conditions

  • Phenylketonurias

Interventions

  • sapropterin dihydrochlorideDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary objective:
  2. - To evaluate the safety and tolerability of long-term Phenoptin treatment in subjects with PKU.

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Los Angeles, California

  • Site not named

    Oakland, California

  • Site not named

    Sacramento, California

  • Site not named

    San Jose, California

  • Site not named

    New Haven, Connecticut

  • Site not named

    Atlanta, Georgia

  • Site not named

    Chicago, Illinois

  • Site not named

    Minneapolis, Minnesota

  • Site not named

    St Louis, Missouri

  • Site not named

    New York, New York

  • Site not named

    Portland, Oregon

  • Site not named

    Dallas, Texas

  • Site not named

    Salt Lake City, Utah

  • Site not named

    Madison, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.